309 related articles for article (PubMed ID: 21862212)
21. Chemotherapeutic Agents-Induced Ceramide-Rich Platforms (CRPs) in Endothelial Cells and Their Modulation.
Nepali PR; Haimovitz-Friedman A
Methods Mol Biol; 2021; 2187():215-221. PubMed ID: 32770509
[TBL] [Abstract][Full Text] [Related]
22. Ceramide-induced cell death/survival in murine osteoblasts.
Hill PA; Tumber A
J Endocrinol; 2010 Aug; 206(2):225-33. PubMed ID: 20466846
[TBL] [Abstract][Full Text] [Related]
23. Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids.
Gatt S; Dagan A
Chem Phys Lipids; 2012 May; 165(4):462-74. PubMed ID: 22387097
[TBL] [Abstract][Full Text] [Related]
24. Nitric oxide, ceramide and sphingomyelinase-coupled receptors: a tale of enzymes and messengers coordinating cell death, survival and differentiation.
Perrotta C; De Palma C; Falcone S; Sciorati C; Clementi E
Life Sci; 2005 Aug; 77(14):1732-9. PubMed ID: 15946697
[TBL] [Abstract][Full Text] [Related]
25. Ceramide metabolite, not intact ceramide molecule, may be responsible for cellular toxicity.
Tserng KY; Griffin RL
Biochem J; 2004 Jun; 380(Pt 3):715-22. PubMed ID: 14998372
[TBL] [Abstract][Full Text] [Related]
26. Ceramide: from embryos to tumors.
Savtchouk IA; Mattie FJ; Ollis AA
Sci STKE; 2007 Jul; 2007(394):jc1. PubMed ID: 17622645
[TBL] [Abstract][Full Text] [Related]
27. Neutral Sphingomyelinases in Cancer: Friend or Foe?
Clarke CJ
Adv Cancer Res; 2018; 140():97-119. PubMed ID: 30060818
[TBL] [Abstract][Full Text] [Related]
28. Augmentation of chemotherapy-triggered glioma cell apoptosis by blockade of arachidonic acid metabolism--the potential role of ceramide accumulation.
Omahen DA
Med Hypotheses; 2011 Nov; 77(5):726-33. PubMed ID: 21862232
[TBL] [Abstract][Full Text] [Related]
29. Ceramide mediates caspase-independent programmed cell death.
Thon L; Möhlig H; Mathieu S; Lange A; Bulanova E; Winoto-Morbach S; Schütze S; Bulfone-Paus S; Adam D
FASEB J; 2005 Dec; 19(14):1945-56. PubMed ID: 16319138
[TBL] [Abstract][Full Text] [Related]
30. Diversity and complexity of ceramide generation after exposure of jurkat leukemia cells to irradiation.
Ardail D; Maalouf M; Boivin A; Chapet O; Bodennec J; Rousson R; Rodriguez-Lafrasse C
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1211-8. PubMed ID: 19251092
[TBL] [Abstract][Full Text] [Related]
31. The protein kinase C activators phorbol esters and phosphatidylserine inhibit neutral sphingomyelinase activation, ceramide generation, and apoptosis triggered by daunorubicin.
Mansat V; Laurent G; Levade T; Bettaïeb A; Jaffrézou JP
Cancer Res; 1997 Dec; 57(23):5300-4. PubMed ID: 9393753
[TBL] [Abstract][Full Text] [Related]
32. Ceramide signalling and the immune response.
Ballou LR; Laulederkind SJ; Rosloniec EF; Raghow R
Biochim Biophys Acta; 1996 Jun; 1301(3):273-87. PubMed ID: 8664339
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of sphingomyelin hydrolysis: targeting the lipid mediator ceramide as a key regulator of cellular fate.
Claus RA; Dorer MJ; Bunck AC; Deigner HP
Curr Med Chem; 2009; 16(16):1978-2000. PubMed ID: 19519377
[TBL] [Abstract][Full Text] [Related]
34. Ceramide accumulation is independent of camptothecin-induced apoptosis in prostate cancer LNCaP cells.
Akao Y; Kusakabe S; Banno Y; Kito M; Nakagawa Y; Tamiya-Koizumi K; Hattori M; Sawada M; Hirabayasi Y; Ohishi N; Nozawa Y
Biochem Biophys Res Commun; 2002 Jun; 294(2):363-70. PubMed ID: 12051721
[TBL] [Abstract][Full Text] [Related]
35. Recent advances in the immunobiology of ceramide.
Pandey S; Murphy RF; Agrawal DK
Exp Mol Pathol; 2007 Jun; 82(3):298-309. PubMed ID: 17045585
[TBL] [Abstract][Full Text] [Related]
36. Targeting ceramide metabolism--a strategy for overcoming drug resistance.
Senchenkov A; Litvak DA; Cabot MC
J Natl Cancer Inst; 2001 Mar; 93(5):347-57. PubMed ID: 11238696
[TBL] [Abstract][Full Text] [Related]
37. New oleyl glycoside as anti-cancer agent that targets on neutral sphingomyelinase.
Romero-Ramírez L; García-Álvarez I; Casas J; Barreda-Manso MA; Yanguas-Casás N; Nieto-Sampedro M; Fernández-Mayoralas A
Biochem Pharmacol; 2015 Sep; 97(2):158-72. PubMed ID: 26206186
[TBL] [Abstract][Full Text] [Related]
38. Role of ceramide/sphingomyelin (SM) balance regulated through "SM cycle" in cancer.
Taniguchi M; Okazaki T
Cell Signal; 2021 Nov; 87():110119. PubMed ID: 34418535
[TBL] [Abstract][Full Text] [Related]
39. Mammalian neutral sphingomyelinases: regulation and roles in cell signaling responses.
Wu BX; Clarke CJ; Hannun YA
Neuromolecular Med; 2010 Dec; 12(4):320-30. PubMed ID: 20552297
[TBL] [Abstract][Full Text] [Related]
40. Ceramide in apoptosis--does it really matter?
Hofmann K; Dixit VM
Trends Biochem Sci; 1998 Oct; 23(10):374-7. PubMed ID: 9810222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
